73168-10-2

Upstream product

• 100-39-0 benzyl bromide 

Downstream Products

• 73168-12-4 1-methyl-6-(phenylmethoxy)-10-<(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)oxy>benzo<1>benzopyrano<5,4,3-cde><1>benzopyran-5,12-dione 
• 73168-13-5 6-Benzyloxy-1-methyl-10-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-benzo[h]chromeno[5,4,3-cde]chromene-5,12-dione 
• 73177-12-5 6-Benzyloxy-10-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-hydroxymethyl-5-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-yloxy]-1-methyl-benzo[h]chromeno[5,4,3-cde]chromene-5,12-dione 
• 73180-38-8 1-methyl-6-(phenylmethoxy)-10<<2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tera-O-acetyl-α-D-glucopyranosyl)-β-D-glucopyranosyl>oxy>benzo<1>benzopyrano<5,4,3-cde><1>benzopyran-5,12-dione 

Relevant academic research and scientific papers

Synthesis and antitumor activity of analogues of the antitumor antibiotic chartreusin

First isolated in 1953 from a fermentation broth, chartreusin (1) has received interest as a result of substantial antitumor activities recently demonstrated in several murine test systems. Poor water solubility frustrated formulation attempts, and rapid